Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) Equity Income (2019 - 2024)

Viemed Healthcare filings provide 6 years of Equity Income readings, the most recent being $96000.0 for Q3 2024.

  • On a quarterly basis, Equity Income fell 64.44% to $96000.0 in Q3 2024 year-over-year; TTM through Jun 2025 was $96000.0, a 113.03% increase, with the full-year FY2024 number at -$954000.0, down 296.7% from a year prior.
  • Equity Income hit $96000.0 in Q3 2024 for Viemed Healthcare, up from -$1.1 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $459000.0 in Q4 2021 to a low of -$1.1 million in Q2 2024.
  • Median Equity Income over the past 5 years was $84000.0 (2022), compared with a mean of $94631.6.
  • Biggest five-year swings in Equity Income: surged 1476.19% in 2021 and later crashed 915.33% in 2024.
  • Viemed Healthcare's Equity Income stood at $55000.0 in 2020, then skyrocketed by 734.55% to $459000.0 in 2021, then crashed by 82.14% to $82000.0 in 2022, then tumbled by 47.56% to $43000.0 in 2023, then surged by 123.26% to $96000.0 in 2024.
  • The last three reported values for Equity Income were $96000.0 (Q3 2024), -$1.1 million (Q2 2024), and $67000.0 (Q1 2024) per Business Quant data.